Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia

PLoS One. 2017 Aug 7;12(8):e0182436. doi: 10.1371/journal.pone.0182436. eCollection 2017.

Abstract

Objectives: We aimed to investigate the association between the time to positivity of blood culture (TTP) with clinical outcome and severity of pneumococcal bacteremic pneumonia.

Methods: Prospective observational study carried out in 278 hospitalized adult CAP patients with positive blood culture for Streptococcus pneumonia (2003-2015).

Results: A total of 278 cases of bacteremic pneumococcal pneumonia were analyzed, median age 62 (46; 79) years. Fifty-one percent of the cases had PSI IV-V. Twenty-one (8%) died within 30-days after admission. The analysis of the TTP showed that the first quartile of the TTP (9.2h) was the best cut-off for differentiating 2 groups of patients at risk, early (TTP <9.2 h) and late (TTP ≥9.2 h) detection groups (AUC 0.66 [95% CI 0.53 to 0.79]). Early TTP was associated with a statistically significant risk of invasive mechanical ventilation (18% vs. 6%, p = 0.007), longer length of hospital stay (12 days vs. 8 days, p<0.001), higher in-hospital mortality (15% vs. 4%, p = 0.010), and 30-day mortality (15% vs. 5%, p = 0.018). After adjustment for potential confounders, regression analyses revealed early TTP as independently associated with high risk of invasive mechanical ventilation (OR 4.60, 95% CI 1.63 to 13.03), longer length of hospital stay (β 5.20, 95% CI 1.81 to 8.52), higher in-hospital mortality (OR 5.35, 95% CI 1.55 to 18.53), and a trend to higher 30-day mortality (OR 2.47, 95% CI 0.85 to 7.21) to be a contributing factor.

Conclusion: Our results demonstrate that TTP is an easy to obtain surrogate marker of the severity of pneumococcal pneumonia and a good predictor of its outcome.

MeSH terms

  • Aged
  • Bacteremia / complications*
  • Blood Culture*
  • Community-Acquired Infections / blood
  • Community-Acquired Infections / complications
  • Community-Acquired Infections / diagnosis
  • Community-Acquired Infections / mortality
  • Female
  • Hospital Mortality
  • Humans
  • Intensive Care Units / statistics & numerical data
  • Length of Stay
  • Male
  • Middle Aged
  • Patient Admission / statistics & numerical data
  • Pneumonia, Pneumococcal / blood*
  • Pneumonia, Pneumococcal / complications
  • Pneumonia, Pneumococcal / diagnosis*
  • Pneumonia, Pneumococcal / mortality
  • Prognosis
  • Respiration, Artificial
  • Time Factors

Grants and funding

Dr. Cillóniz is a recipient of ERS Short Term Fellowship and Postdoctoral Junior Grants 2013 Ministerio de Economía y Competitividad, Spain and “Strategic Plan for Research and Innovation in Health, PERIS 2016-2020.” Dr. Ceccato is a recipient of ERS Long-term Fellowship. This work was supported by Ciber de Enfermedades Respiratorias [CibeResCB06/06/0028], 2009 Support to Research Groups of Catalonia 911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.